Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV (levoketoconazole) for the Treatment of Cushing’s Syndrome

firstwordpharmaJune 04, 2021

Tag: RECORLEV , levoketoconazole , Cushing’s Syndrome

PharmaSources Customer Service